Log in

NASDAQ:CPRXCatalyst Pharmaceuticals SEC Filings & 10K Form

$4.49
+0.16 (+3.70 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.32
Now: $4.49
$4.49
50-Day Range
$4.26
MA: $4.60
$5.05
52-Week Range
$2.55
Now: $4.49
$7.67
Volume1.98 million shs
Average Volume1.81 million shs
Market Capitalization$463.84 million
P/E Ratio11.21
Dividend YieldN/A
Beta1.93

SEC Filings

Catalyst Pharmaceuticals (NASDAQ:CPRX) SEC Filings

DateFilerForm TypeView
05/13/2020
3:30 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
4:21 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2020
7:09 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
3:39 PM
ARMISTICE CAPITAL, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G
03/16/2020
4:24 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2020
4:19 PM
Broadfin Capital, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2020
7:00 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:59 PM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
01/06/2020
7:55 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
3:37 PM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
12/06/2019
3:52 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:29 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:27 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:26 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:25 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:24 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:23 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:21 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:20 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:19 PM
BRENNAN DANIEL (Reporting)
Catalyst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:18 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
4:16 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
4:02 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:23 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
4:06 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:45 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:33 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2019
7:09 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
1:58 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
2:10 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
3:37 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
7:27 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
4:18 PM
Catalyst Pharmaceuticals (Filer)
Form 424B5
08/30/2019
3:32 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:29 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:09 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/12/2019
4:12 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
1:06 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
4:02 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
4:01 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
3:15 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
7:09 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
4:16 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/18/2019
4:15 PM
Catalyst Pharmaceuticals (Filer)
Form DEF 14A
03/18/2019
3:37 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
3:08 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2019
8:18 AM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
02/27/2019
10:29 AM
Catalyst Pharmaceuticals (Filer)
Form CT ORDER
02/14/2019
10:15 AM
Catalyst Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2019
3:26 PM
Broadfin Capital, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
01/04/2019
3:45 PM
Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/28/2018
11:29 AM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2018
4:01 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2018
3:48 PM
Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:48 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
COELHO PHILIP H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:46 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:46 PM
Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:46 PM
BRENNAN DANIEL (Reporting)
Catalyst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:46 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:45 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2018
3:25 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
3:49 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
3:19 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:50 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
7:29 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:41 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:08 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/28/2018
11:23 AM
Catalyst Pharmaceuticals (Filer)
Form CT ORDER
08/17/2018
4:15 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
4:16 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
4:00 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
4:00 PM
BRENNAN DANIEL (Reporting)
Catalyst Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2018
7:48 AM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
3:26 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
2:35 PM
Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
4:00 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2018
10:57 AM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
7:20 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2018
4:25 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
3:41 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2018
3:06 PM
Catalyst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2018
7:30 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2018
4:16 PM
Catalyst Pharmaceuticals (Filer)
Form DEF 14A
04/03/2018
3:13 PM
Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
7:37 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2018
3:27 PM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2018
3:05 PM
Catalyst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2018
3:50 PM
Catalyst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
02/13/2018
3:31 PM
Broadfin Capital, LLC (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
3:09 PM
BAKER BROS. ADVISORS LP (Filed by)
Catalyst Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2018
7:24 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2018
9:42 AM
Catalyst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2018
3:58 PM
Catalyst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
3:50 PM
Catalyst Pharmaceuticals (Issuer)
GRANDE ALICIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
3:48 PM
Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
3:47 PM
Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.